PTI - Proteostasis Therapeutics, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 552.12M
Enterprise Value 3-39.21M
Trailing P/E N/A
Forward P/E 1-0.66
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)7.56
Price/Book (mrq)0.52
Enterprise Value/Revenue 3-5.68
Enterprise Value/EBITDA 60.60

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-971.18%

Management Effectiveness

Return on Assets (ttm)-40.70%
Return on Equity (ttm)-80.97%

Income Statement

Revenue (ttm)6.9M
Revenue Per Share (ttm)0.16
Quarterly Revenue Growth (yoy)430.80%
Gross Profit (ttm)2.84M
EBITDA -65.43M
Net Income Avi to Common (ttm)-65.22M
Diluted EPS (ttm)-1.5300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)105.33M
Total Cash Per Share (mrq)2.06
Total Debt (mrq)14M
Total Debt/Equity (mrq)13.87
Current Ratio (mrq)11.30
Book Value Per Share (mrq)1.98

Cash Flow Statement

Operating Cash Flow (ttm)-60.24M
Levered Free Cash Flow (ttm)-35.34M

Trading Information

Stock Price History

Beta (3Y Monthly) -1.82
52-Week Change 3-62.99%
S&P500 52-Week Change 39.10%
52 Week High 310.3800
52 Week Low 30.9100
50-Day Moving Average 31.0487
200-Day Moving Average 32.5153

Share Statistics

Avg Vol (3 month) 31.72M
Avg Vol (10 day) 3552.67k
Shares Outstanding 551.1M
Float 34.42M
% Held by Insiders 117.52%
% Held by Institutions 179.59%
Shares Short (May 31, 2019) 45.94M
Short Ratio (May 31, 2019) 45.62
Short % of Float (May 31, 2019) 415.32%
Short % of Shares Outstanding (May 31, 2019) 411.63%
Shares Short (prior month Apr 30, 2019) 45.84M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A